[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2086022T3 - Composiciones estables para administracion parenteral y su uso. - Google Patents

Composiciones estables para administracion parenteral y su uso.

Info

Publication number
ES2086022T3
ES2086022T3 ES92107277T ES92107277T ES2086022T3 ES 2086022 T3 ES2086022 T3 ES 2086022T3 ES 92107277 T ES92107277 T ES 92107277T ES 92107277 T ES92107277 T ES 92107277T ES 2086022 T3 ES2086022 T3 ES 2086022T3
Authority
ES
Spain
Prior art keywords
compounds
parenteral administration
lambda
warm
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92107277T
Other languages
English (en)
Inventor
Susan Mancini Cady
William David Steber
Phillip Wayne Hayes
Mary Ehlers Doscher
Kurt Allen Schwinghammer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ES2086022T3 publication Critical patent/ES2086022T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

EL INVENTO DESCRIBE CIERTOS COMPUESTOS DE MICROESFERAS ESTABLES CON CONTENIDO DE GRASA O CERA O UNA MEZCLA DE AMBAS; UN INGREDIENTE ACTIVO SELECCIONADO DE COMPUESTO LL-F28249ALFA-LAMBDA, DERIVADOS 23-OXO Y 23-IMINO DE COMPUESTOS LL-F28249ALFA-LAMBDA, COMPUESTOS DE MILBECINA Y COMPUESTOS DE AVERNECTINA; UN ACEITE, GRASA SEMI-BLANDA, DERIVADO DE ACIDO GRASO O MEZCLA DE ELLOS; Y UN ANTIOXIDANTE. EL INVENTO TAMBIEN DESCRIBE UN METODO DE INTRODUCIR Y MANTENER NIVELES DEL COMPUESTO ACTIVO EN LA SANGRE DE ANIMALES DE SANGRE CALIENTE PERIODOS EXTENDIDOS DE TIEMPO Y LA PREVENCION O TRATAMIENTO DE INFECCIONES E INFESTACIONES CAUSADAS POR HELMINTOS, NEMATODOS, ACARIDOS Y ARTROPOODOS ENDO Y ECTOPARASITOS EN ANIMALES DE SANGRE CALIENTE POR LA ADMINISTRACION PARENTENAL DE COMPUESTOS DEL INVENTO.
ES92107277T 1991-07-23 1992-04-29 Composiciones estables para administracion parenteral y su uso. Expired - Lifetime ES2086022T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73443091A 1991-07-23 1991-07-23

Publications (1)

Publication Number Publication Date
ES2086022T3 true ES2086022T3 (es) 1996-06-16

Family

ID=24951666

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92107277T Expired - Lifetime ES2086022T3 (es) 1991-07-23 1992-04-29 Composiciones estables para administracion parenteral y su uso.

Country Status (21)

Country Link
US (1) US6340671B1 (es)
EP (1) EP0525307B1 (es)
JP (1) JP3470904B2 (es)
KR (1) KR100235550B1 (es)
CN (1) CN1046852C (es)
AT (1) ATE134873T1 (es)
AU (1) AU651229B2 (es)
BR (1) BR9202771A (es)
CA (1) CA2074348C (es)
DE (1) DE69208765T2 (es)
DK (1) DK0525307T3 (es)
ES (1) ES2086022T3 (es)
GR (1) GR3019234T3 (es)
HK (1) HK1000005A1 (es)
HU (1) HU220595B1 (es)
IE (1) IE74401B1 (es)
IL (1) IL102567A (es)
MX (1) MX9204135A (es)
NZ (1) NZ243619A (es)
TW (1) TW201696B (es)
ZA (1) ZA925522B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5686092A (en) * 1992-11-24 1997-11-11 Alkermes Controlled Therapeutics Inc. Ii Growth promoters for animals
DE4308282C2 (de) * 1993-03-16 1994-12-22 Beiersdorf Ag Vorzugsweise in Form von Mikrosphärulen vorliegende galenische Matrices
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
AU4917900A (en) * 1999-05-07 2000-11-21 Pharmasol Gmbh Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
US8663692B1 (en) * 1999-05-07 2014-03-04 Pharmasol Gmbh Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
DK1197207T3 (da) * 2000-10-10 2008-08-04 Wyeth Corp Stabile sammensætninger til parenteral indgivelse
FR2852843B1 (fr) 2003-03-24 2008-05-23 Karim Ioualalen Systeme galenique permettant le masquage du gout
NZ534939A (en) * 2004-08-26 2007-04-27 Bomac Research Ltd Injectable formulation comprising an anthelmintic compound with complexing compound for improved solubility
BR112012008185A2 (pt) 2009-10-07 2016-08-16 Wyeth Llc composições que compreendem adjuvante, macrolídeo e antígeno proteináceo, e métodos para uso dessas composições
ITUB20153652A1 (it) 2015-09-16 2017-03-16 Fatro Spa Microsfere contenenti lattoni macrociclici antielminitici
US11318156B2 (en) 2017-04-13 2022-05-03 Ceva Sante Animale Solid injectable veterinary implants comprising monocyclic lactone
AU2020224158A1 (en) * 2019-02-21 2021-09-30 ChromaDex Inc. Use of nicotinamide riboside, nicotinic acid riboside, reduced nicotinyl riboside compounds, and nicotinyl riboside compound derivatives in formulations
PE20220173A1 (es) 2019-05-03 2022-01-28 Intervet Int Bv Composiciones farmaceuticas inyectables y usos de las mismas
AU2021277491B2 (en) 2020-05-20 2024-05-16 Intervet International B.V. Injectable pharmaceutical compositions and uses thereof
WO2022263505A1 (en) * 2021-06-16 2022-12-22 Société des Produits Nestlé S.A. Methods of solid phase wax coating of an active ingredient
WO2024003291A1 (en) 2022-06-30 2024-01-04 Virbac Deslorelin use in chemical castration of a non-human mammal related to pk/pd interaction

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3659022A (en) * 1967-11-13 1972-04-25 Upjohn Co Methods of preventing impregnation
US4144352A (en) * 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US5169956A (en) * 1984-06-05 1992-12-08 American Cyanamid Company Macrolide antibiotic compounds
US5106994A (en) * 1984-06-05 1992-04-21 American Cyanamid Company Agents and method of production thereof
ES2039219T3 (es) * 1986-08-11 1993-09-16 American Cyanamid Company Composiciones para administracion parenteral y su uso.
GB8803836D0 (en) * 1988-02-18 1988-03-16 Glaxo Group Ltd Compositions
ATE103173T1 (de) * 1989-02-28 1994-04-15 American Cyanamid Co Bolus mit lang andauernder wirkstoffabgabe, wirksam bei der prophylaxe, behandlung oder bekaempfung des befalls bei wiederkaeuern durch fadenwuermer, milben und endo- und ektoparasiten.
US5213810A (en) * 1990-03-30 1993-05-25 American Cyanamid Company Stable compositions for parenteral administration and method of making same
US5346698A (en) * 1991-01-15 1994-09-13 Mycogen Corporation Synergistic pesticidal compositions
US5192546A (en) * 1991-01-15 1993-03-09 Mycogen Corporation Synergistic pesticidal compositions
US5185108A (en) * 1991-07-10 1993-02-09 The B. F. Goodrich Company Method for producing wax microspheres
JP4654917B2 (ja) 2006-01-12 2011-03-23 日産自動車株式会社 車体後部構造

Also Published As

Publication number Publication date
IL102567A (en) 1996-10-31
IE74401B1 (en) 1997-07-30
HK1000005A1 (en) 1997-10-03
KR930001904A (ko) 1993-02-22
DK0525307T3 (da) 1996-04-01
CN1046852C (zh) 1999-12-01
ATE134873T1 (de) 1996-03-15
EP0525307B1 (en) 1996-03-06
BR9202771A (pt) 1993-03-23
DE69208765T2 (de) 1996-09-26
TW201696B (es) 1993-03-11
HU9202404D0 (en) 1992-10-28
MX9204135A (es) 1993-01-01
JP3470904B2 (ja) 2003-11-25
IE922373A1 (en) 1993-01-27
AU651229B2 (en) 1994-07-14
CA2074348C (en) 2004-02-17
CA2074348A1 (en) 1993-01-24
IL102567A0 (en) 1993-01-14
DE69208765D1 (de) 1996-04-11
EP0525307A1 (en) 1993-02-03
ZA925522B (en) 1993-04-28
HUT62454A (en) 1993-05-28
NZ243619A (en) 1994-12-22
AU2047292A (en) 1993-01-28
US6340671B1 (en) 2002-01-22
KR100235550B1 (ko) 1999-12-15
GR3019234T3 (en) 1996-06-30
JPH05194211A (ja) 1993-08-03
HU220595B1 (hu) 2002-03-28
CN1068735A (zh) 1993-02-10

Similar Documents

Publication Publication Date Title
ES2086022T3 (es) Composiciones estables para administracion parenteral y su uso.
NO2011026I2 (no) Eribulin eller et farmasøytisk akseptabelt salt derav
DK1679064T3 (da) Farmaceutiske sammensætninger indeholdende rapamycinderivater
CY1108145T1 (el) Σταθερες συνθεσεις για παρεντερικη χορηγηση
CY1110261T1 (el) Παραγωγα της κουμαρινης που χρησιμοποιουνται σαν αντιπηκτικα
MX17808A (es) Nuevos derivados de artemisinina,procedimiento para su preparacion y su uso como agentes antiprosoos
KR920007629A (ko) SALMe염, 5-MTHF 및 5-FTHF 중에서 선택된 화합물 적어도 1개를 유효성분으로서 함유하여 AIDS환자의 신경학적 질환치료시 활성을 나타내는 약제학적 조성물
KR960016889A (ko) 뇌기능 개선제
KR900006330A (ko) 피롤로[3,2-e]피라졸로[1,5-a]피리미딘 유도체 및 이를 함유하는 약제
KR910006242A (ko) 6-치환된 아시클로피리미딘 뉴클레오시드 유도체 및 이를 활성 성분으로 함유하는 항비루스제
ES2144154T3 (es) Derivados de eritromicina a 9-0-oxima dotados de actividad antibiotica.
ATE207492T1 (de) Difluoroavermectin-derivate
ES344613A1 (es) Procedimiento para la preparacion de trimetilsilil eteres.
KR900701795A (ko) 티에노시클로 헵타피리다진 화합물과 그것의 의약용도
ES2132283T3 (es) Derivados n-heteroaril sustituidos de propanamida utiles en el tratamiento de enfermedades cardiovasculares.
KR950703956A (ko) 순환 장애 개선제[circulatory disturbance ameliorant]
SE8001235L (sv) 2,2-dimetyl-1,2-dihydrokinolinderivat anvendbara som antioxidanter, jemte sett for deras framstellning och blandningar innehallande dem
PT1100463E (pt) Novas formulacoes injectaveis contendo ramoplanina
JPS5480426A (en) Agent for prophylaxis and remedy of mycoplasmosis
KR920701163A (ko) 퀴놀론 카르복실산 유도체
NO993008L (no) Preparat som tiltrekker barkebiller
KR830006182A (ko) 신규한 옥시아세트산 유도체, 그의 제법 및 그것을 유효성분으로 하는 혈중지질 저하제(血中脂質低下劑)
RU2000123650A (ru) 5'-замещенные производные 3'-азидо-3'-дезокситимидина и фармацевтические композиции на их основе
KR950011399A (ko) 살균성 인다닐아민 화합물, 이의 유도체 및 이들의 제조방법

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 525307

Country of ref document: ES